- Home
- products
- south korea
- bioinformatics
Show results for
Refine by
Bioinformatics Equipment Supplied In South Korea
5 equipment items found
Manufactured by:Celemics, Inc. based inSeoul, SOUTH KOREA
Celemics Whole Exome panel is a comprehensive solution that covers all target regions of major WES panels available in the market. Celemics Whole Exome is a comprehensive whole exome panel that covers the target regions of major WES panels in the market. With the target size of 37 Mb, the panel does not compromise performance in terms of coverage and uniformity, enabling highly efficient and ...
Manufactured by:Celemics, Inc. based inSeoul, SOUTH KOREA
Celemics’ BRCA 1,2 Target Enrichment Panel is designed to enrich whole coding sequences (CDS) of the BRCA1 and BRCA2 genes including UTR, promoter, and +/- 40 bases of CDS to detect the variants in the splicing ...
Manufactured by:Celemics, Inc. based inSeoul, SOUTH KOREA
“Unlike Whole Genome Sequencing, Targeted Sequencing is a technique that selectively analyzes specific regional sequences of genomes.” Our Target Enrichment Panel uses hybridization-based capture technology to enable the core process of Target Sequencing, which is the separation and analysis of specific regional sequences of entire genomes. It can also accurately analyze all types of ...
Manufactured by:LISCure Biosciences Inc. based inSeongnam-si, SOUTH KOREA
The LMT (LISCure Microbiology-based Technology) platform is an innovative tool to keep discovering and analyzing microbial and genome-based drug candidates. LMT (LISCure Microbiology-based Technology) Platform Consists of the Therapeutic Screening Platform, Microbial Optimization Platform, and Microbiome Database ...
Manufactured by:IMB Dx, Inc. based inSeoul, SOUTH KOREA
Tissue specimens are either from surgical resections or biopsies which may raise the risk of bleeding, and infection and further require recovery from the procedure. Genomic profiling of tissue samples provides a single point in space and time which is lacking the ability to reveal tumor heterogeneity and to test repeatedly to monitor the treatment efficacy. The risk of tissue biopsy is much ...